Sarah Lowry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sarah Lowry has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andy Kaempf
Cancer Data Science Shared Resource OHSU, Knight Cancer Institute Portland Oregon USA
1 shared publication - Cameron Chalker
Division of Hematology and Medical Oncology Oregon Health & Science University (OHSU), Knight Cancer Institute Portland Oregon USA
1 shared publication - Carol Mulvenon
Clinical Nurse Specialist, Palliative Care, The University of Kansas Health System, Kansas City, Kansas
1 shared publication - Chetan V. Vakkalagadda
Division of Hematology and Medical Oncology Oregon Health & Science University (OHSU), Knight Cancer Institute Portland Oregon USA
1 shared publication - Eric Roeland
Oregon Health and Science University
1 shared publication Erynn A. Beeson
Division of Palliative Medicine University of California San Francisco San Francisco California USA
1 shared publication
Latest Publications
- 23 October 2026
- Published by Wiley in Head & Neck
Exploring G‐Tube Timing and Clinical Outcomes in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Chemoradiation
Background: G‐tube placement timing remains poorly characterized in patients with localized head and neck cancer (HNSCC) undergoing definitive chemoradiation (dCRT). Methods: We retrospectively analyzed 144 patients with HNSCC who received dCRT (2019–2024), categorized by “upfront” or “as‐needed” G‐tube strategy, to explore factors associated with timing and outcomes using propensity score weighting. Results: Most patients were White (85%) and male (83%); median age was 63 years. Upfront G‐tube placement occurred in 60 patients (42%) and was more common among women (64% vs. 37%, p = 0.015) and those with dysphagia (55% vs. 28%, p = 0.001) or receiving induction chemotherapy (71% vs. 38%, p = 0.023). dCRT duration, weight loss, ED visits, hospitalizations, ICU admissions, and survival did not differ. Upfront placement was associated with lower odds of chemotherapy modification (73% lower, p = 0.007) and fewer infusion clinic visits (average 3 fewer, p = 0.038). Conclusion: These findings suggest multiple factors influence G‐tube timing and outcomes, warranting prospective validation.
- 23 October 2026
- Published by Wiley in Head & Neck
Exploring G‐Tube Timing and Clinical Outcomes in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Chemoradiation
Background: G‐tube placement timing remains poorly characterized in patients with localized head and neck cancer (HNSCC) undergoing definitive chemoradiation (dCRT). Methods: We retrospectively analyzed 144 patients with HNSCC who received dCRT (2019–2024), categorized by “upfront” or “as‐needed” G‐tube strategy, to explore factors associated with timing and outcomes using propensity score weighting. Results: Most patients were White (85%) and male (83%); median age was 63 years. Upfront G‐tube placement occurred in 60 patients (42%) and was more common among women (64% vs. 37%, p = 0.015) and those with dysphagia (55% vs. 28%, p = 0.001) or receiving induction chemotherapy (71% vs. 38%, p = 0.023). dCRT duration, weight loss, ED visits, hospitalizations, ICU admissions, and survival did not differ. Upfront placement was associated with lower odds of chemotherapy modification (73% lower, p = 0.007) and fewer infusion clinic visits (average 3 fewer, p = 0.038). Conclusion: These findings suggest multiple factors influence G‐tube timing and outcomes, warranting prospective validation.
- Open Access
- 1 May 2024
- Published by Elsevier in Pain Management Nursing
- Vol. 25 (4) , 327-329
American Society for Pain Management Nursing and Hospice and Palliative Nurses Association Position Statement: Pain Management at the End of Life
- 1 May 2024
- Published by Elsevier in Pain Management Nursing
- Vol. 25 (4) , 327-329
Open AccessAmerican Society for Pain Management Nursing and Hospice and Palliative Nurses Association Position Statement: Pain Management at the End of Life